Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%

RTTNews | 1291 hari yang lalu
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%

(RTTNews) - Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.

The products include both pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, specifically Levemir, Novolin, NovoLog and NovoLog Mix 70/30.

Novo Nordisk is also reducing the list price of unbranded biologics to match the lowered price of each respective branded insulin. These changes will go into effect on January 1, 2024.

Novo Nordisk currently provides co-pay support for a number of insulin products, meaning eligible patients can pay $25 to $35 for their insulin.

Novo Nordisk recognizes that some patients find it difficult to pay for healthcare, including insulin. As such, the Company remains committed to reducing the burden of out-of-pocket costs, helping transform the complex pricing system, and fostering better pricing predictability.

Novo Nordisk continually reviews and revises its offerings as well as works with diverse stakeholders to create solutions for differing patient needs.

baca selengkapnya
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook

Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook

Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews | 506 hari yang lalu
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply

Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply

Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews | 822 hari yang lalu
Swiss Market Ends Modestly Higher

Swiss Market Ends Modestly Higher

The Switzerland market ended modestly higher on Friday, after moving in a narrow range in positive territory right through the session. Lower oil prices and bond yields amid hopes about potential opening of the Strait of Hormuz in seven days lifted investor sentiment.
RTTNews | 2 jam 5 menit yang lalu
European Stocks Rise On Oil Decline, Middle East Peace Hopes

European Stocks Rise On Oil Decline, Middle East Peace Hopes

European stocks rose Friday following a more than 2% decline in Brent crude futures and falling bond yields, supported by reports that Iran has submitted a proposal to end Middle East hostilities. Major indices including the DAX and FTSE 100 posted modest gains.
RTTNews | 2 jam 32 menit yang lalu
U.S. Consumer Sentiment Drops Less Than Previously Estimated In September

U.S. Consumer Sentiment Drops Less Than Previously Estimated In September

Revised data released by the University of Michigan on Friday showed consumer sentiment in the U.S. deteriorated by less than previously estimated in the month of September. The University of Michigan said its consumer sentiment index for September was upwardly revised to 48.1 from a preliminary reading of 47.8.
RTTNews | 6 jam 38 menit yang lalu
Bay Street Poised For Positive Open On Metal Gains

Bay Street Poised For Positive Open On Metal Gains

Higher gold and silver futures support Canadian stock sentiment Friday morning. Iranian officials have submitted peace proposals to U.S. mediators this week. BlackBerry's adjusted net income rose 79% to $43.2 mln in the second quarter.
RTTNews | 8 jam 17 menit yang lalu